2-piperidone has been researched along with Cancer of Endometrium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohn, DE; Goodfellow, PJ; Kuppusamy, P; McCann, GA; Naidu, S; Rath, KS; Saini, U; Selvendiran, K; Suarez, A; Tierney, BJ; Wanner, R | 1 |
1 other study(ies) available for 2-piperidone and Cancer of Endometrium
| Article | Year |
|---|---|
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor.
Topics: Animals; Cell Line, Tumor; Endometrial Neoplasms; Female; Humans; Mice; Piperidones; STAT3 Transcription Factor | 2014 |